{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:33:02Z","timestamp":1792996382284,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015673","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000}}],"reference-count":196,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015673.pub2","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T07:29:27Z","timestamp":1742542167000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Combined pharmacological and psychosocial interventions for alcohol use disorder"],"prefix":"10.1002","volume":"2025","author":[{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Lazio Regional Health Service; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy Rita Maria","family":"La Rosa","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine; University of Catania; Catania Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neurosciences and Clinical Pharmacology; University of Cagliari; Monserrato (Cagliari) Italy"},{"name":"Department of Medical Sciences and Public Health; University of Cagliari; Cagliari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Camposeragna","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Lazio Regional Health Service; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Saulle","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Lazio Regional Health Service; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[{"name":"Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch; National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Agabio","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neurosciences and Clinical Pharmacology; University of Cagliari; Monserrato (Cagliari) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00004714-200102000-00013","article-title":"Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism","volume":"21","author":"Anton","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0002|cit2","unstructured":"Anton RF Moak DH Waid LR Latham PK Dias JK Naltrexone plus cognitive-behavior therapy for alcoholism 152nd Annual Meeting of the American Psychiatric Association Washington, DC 1999"},{"issue":"11","key":"10.1002\/14651858.CD015673.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/01.jcp.0000172071.81258.04","article-title":"Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence","volume":"25","author":"Anton","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1530-0277.2007.00343.x","article-title":"What role does measuring medication compliance play in evaluating the efficacy of naltrexone?","volume":"31","author":"Baros","year":"2007","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0006|cit6","unstructured":"Naltrexone treatment of alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT00000452"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0007|cit7","unstructured":"Behavioral therapy plus naltrexone for alcoholism https:\/\/clinicaltrials.gov\/study\/NCT00000456"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/ADM.0000000000000925","article-title":"The relationship between reductions in WHO risk drinking levels during treatment and subsequent healthcare costs for the ACTIVE workgroup","volume":"16","author":"Aldridge","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"17","key":"10.1002\/14651858.CD015673.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0010|cit10","first-page":"39","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence","volume":"28","author":"Anton","year":"2011","journal-title":"Psychiatric Times"},{"issue":"7","key":"10.1002\/14651858.CD015673.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/01.ALC.0000078020.92938.0B","article-title":"Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study","volume":"27","author":"COMBINE Study Research Group","year":"2003","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"7","key":"10.1002\/14651858.CD015673.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/00000374-200307000-00011","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods","volume":"27","author":"COMBINE Study Research Group","year":"2003","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"14","key":"10.1002\/14651858.CD015673.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1727; author re","DOI":"10.1001\/jama.296.14.1727-a","article-title":"Pharmacotherapy and behavioral intervention for alcohol dependence","volume":"296","author":"Jonas","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.15288\/jsad.2009.70.186","article-title":"Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study","volume":"70","author":"LoCastro","year":"2009","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0015|cit15","first-page":"198A","article-title":"Therapeutic processes in the combined behavioral intervention","volume":"33 (Suppl 1)","author":"Moyers","year":"2009","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0016|cit16","unstructured":"COMBINE (acamprosate\/naltrexone) https:\/\/clinicaltrials.gov\/study\/NCT00006206"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.drugalcdep.2009.07.006","article-title":"Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE study","volume":"105","author":"Ray","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0018|cit18","first-page":"S299","article-title":"Moderation and mediation in the combine study for treatments of alcoholism","volume":"173 Suppl 11","author":"Subbaraman","year":"2011","journal-title":"American Journal of Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD015673.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/add.12238","article-title":"Cravings as a mediator and moderator of drinking outcomes in the COMBINE study","volume":"108","author":"Subbaraman","year":"2013","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.15288\/jsad.2008.69.878","article-title":"Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study","volume":"69","author":"Weiss","year":"2008","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/acer.12605","article-title":"Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study","volume":"39","author":"Worley","year":"2015","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"9","key":"10.1002\/14651858.CD015673.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/j.1530-0277.2008.00743.x","article-title":"Relationship between medication adherence and treatment outcomes: the COMBINE study","volume":"32","author":"Zweben","year":"2008","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"7","key":"10.1002\/14651858.CD015673.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","article-title":"A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence","volume":"27","author":"Balldin","year":"2003","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"11","key":"10.1002\/14651858.CD015673.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1530-0277.2009.01024.x","article-title":"A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence","volume":"33","author":"Brown","year":"2009","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0025|cit25","unstructured":"Naltrexone for bipolar disorder and alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT00223275"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/alcalc\/37.4.375","article-title":"Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?","volume":"37","author":"De Wildt","year":"2002","journal-title":"Alcohol and Alcoholism"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial","volume":"21","author":"Hein\u00e4l\u00e4","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1530-0277.1998.tb03703.x","article-title":"Sustained-release naltrexone for alcoholism treatment: a preliminary study","volume":"22","author":"Kranzler","year":"1998","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"7","key":"10.1002\/14651858.CD015673.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/01.alc.0000130804.08397.29","article-title":"Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial","volume":"28","author":"Kranzler","year":"2004","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"24","key":"10.1002\/14651858.CD015673.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1530-0277.2007.00555.x","article-title":"Naltrexone is associated with reduceddrinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA cooperative study no. 425, \"Naltrexone in the treatment of alcoholism\"","volume":"32","author":"Krystal","year":"2008","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"11","key":"10.1002\/14651858.CD015673.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence. A controlled study","volume":"49","author":"O'Malley","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0034|cit34","unstructured":"Naltrexone treatment for alcoholic women https:\/\/clinicaltrials.gov\/study\/NCT00000448"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1530-0277.2007.00347.x","article-title":"Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial","volume":"31","author":"O'Malley","year":"2007","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.drugalcdep.2008.01.010","article-title":"The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence","volume":"95","author":"Dundon","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1002\/14651858.CD015673.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","article-title":"A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention","volume":"32","author":"Oslin","year":"2008","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0038|cit38","unstructured":"Modafinil and naltrexone to reduce cocaine and alcohol dependence (Mod-Nal) https:\/\/clinicaltrials.gov\/study\/NCT00142818"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0039|cit39","unstructured":"Naltrexone in two models of psychosocial treatments for cocaine and alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT00167232"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0040|cit40","unstructured":"Naltrexone in two models of psychosocial treatments for cocaine and alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT00218660"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jsat.2007.05.011","article-title":"Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence","volume":"34","author":"Pettinati","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.addbeh.2007.11.011","article-title":"A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence","volume":"33","author":"Pettinati","year":"2008","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0043|cit43","unstructured":"Vivitrol as a treatment for cocaine and alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT00777062"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1521-0391.2014.12146.x","article-title":"A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence","volume":"23","author":"Pettinati","year":"2014","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0045|cit45","unstructured":"Combined treatment for cocaine-alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT00218569"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/10550490903077929","article-title":"High-dose naltrexone therapy for cocaine-alcohol dependence","volume":"18","author":"Schmitz","year":"2009","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0047|cit47","unstructured":"Naltrexone in the treatment of concurrent alcohol dependence and pathological gambling https:\/\/clinicaltrials.gov\/study\/NCT00326807"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10550490902787007","article-title":"A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling","volume":"18","author":"Toneatto","year":"2009","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0049|cit49","unstructured":"Antabuse in severe alcoholism: an open controlled study https:\/\/clinicaltrials.gov\/study\/NCT00431262"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/08039481003686180","article-title":"Disulfiram in severe alcoholism \u2013 an open controlled study","volume":"64","author":"Ulrichsen","year":"2010","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"117A","DOI":"10.1111\/j.1530-0277.2009.00957.x","article-title":"Treatment of alcohol dependence with disulfiram; an open controlled study","volume":"33 Suppl 1","author":"Ulrichsen","year":"2009","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0052|cit52","unstructured":"Integrative therapy in alcoholism https:\/\/clinicaltrials.gov\/study\/NCT00159107"},{"issue":"2-3","key":"10.1002\/14651858.CD015673.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.drugalcdep.2011.05.001","article-title":"The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial","volume":"118","author":"W\u00f6lwer","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0168-8278(23)00447-6","article-title":"Naltrexone is safe and effective in achieving abstinence and reducing alcohol craving in cirrhotic patients: a double-blind randomized placebo controlled trial","volume":"78 Suppl 1","author":"Alla","year":"2023","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1530-0277.2008.00633.x","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?","volume":"32","author":"Baros","year":"2008","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/acer.12010","article-title":"Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study","volume":"37","author":"Berger","year":"2013","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0057|cit57","unstructured":"Study of Campral (acamprosate) for alcohol dependence in a family medicine clinic https:\/\/clinicaltrials.gov\/study\/NCT00381043"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1118-25","DOI":"10.1111\/acer.12317","article-title":"The place of additional individual psychotherapy in the treatment of alcoholism: a randomized controlled study in nonresponders to anticraving medication \u2013 results of the PREDICT study","volume":"38","author":"Berner","year":"2014","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"10","key":"10.1002\/14651858.CD015673.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1176\/ajp.144.10.1310","article-title":"Psychiatric complications of disulfiram treatment","volume":"144","author":"Branchey","year":"1987","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"587-93","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0061|cit61","unstructured":"Morgan M UK multicentre study of naltrexone as adjunctive therapy in the treatment of alcoholism \u2013 safety results X World Congress of Psychiatry 1996"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-007-0807-y","article-title":"Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment","volume":"194","author":"Davidson","year":"2007","journal-title":"Psychoparmacology (Berlin)"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0063|cit63","unstructured":"A 52-week, randomised, double-blind, placebo-controlled, parallel-group, safety, tolerability and efficacy study of nalmefene, as needed use, in patients with alcohol dependence https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2007-002315-92\/CZ"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"443-8","DOI":"10.1046\/j.1440-1614.2001","article-title":"Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome","volume":"35","author":"Feeney","year":"2001","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"16","key":"10.1002\/14651858.CD015673.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0066|cit66","doi-asserted-by":"crossref","unstructured":"Hoeller K Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial JAMA 2005 293 16 1978","DOI":"10.1001\/jama.293.16.1978-c"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000259166","article-title":"Acamprosate and prevention of relapse in alcoholics. Results of a randomized, placebo-controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg","volume":"3","author":"Geerlings","year":"1997","journal-title":"European Addiction Research"},{"issue":"9","key":"10.1002\/14651858.CD015673.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1097\/01.ALC.0000030561.15921.A9","article-title":"A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial","volume":"26","author":"Guardia","year":"2002","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"289-92","DOI":"10.1080\/13556210500223504","article-title":"A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan","volume":"10","author":"Huang","year":"2005","journal-title":"Addiction Biology"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0070|cit70","unstructured":"Laaksonen E Alho H Salaspuro M Supervised disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence: a randomized controlled study 66th Annual Scientific Meeting of College on Problems of Drug Dependence 2004"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"367-76","DOI":"10.1007\/s00213-009-1615-3","article-title":"Extended naltrexone and broad spectrum treatment or motivational enhancement therapy","volume":"206","author":"Longabaugh","year":"2009","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD015673.pub2-BIB0072|cit72","first-page":"1634-47","article-title":"Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes","volume":"25","author":"Monti","year":"2001","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1037\/a0028615","article-title":"A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men","volume":"80","author":"Morgenstern","year":"2012","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0074|cit74","unstructured":"Medication and counseling for controlled drinking (project SMART) https:\/\/clinicaltrials.gov\/study\/NCT00444418"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/alcalc\/agg038","article-title":"Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study","volume":"38","author":"Namkoong","year":"2003","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0076|cit76","unstructured":"Adaptive treatment for alcohol dependence https:\/\/clinicaltrials.gov\/study\/NCT02689674"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0077|cit77","unstructured":"RCT of an integrated digital intervention for alcohol use disorder https:\/\/clinicaltrials.gov\/study\/NCT05748639"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0078|cit78","unstructured":"Randomized placebo-controlled clinical trial to assess the impact of extended-release naltrexone on HIV treatment outcomes among HIV-1 infected men who have sex with men and transgender women with alcohol use disorders in Lima, Peru https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=PER-083-12"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0079|cit79","first-page":"130","article-title":"Naltrexone in the treatment of alcohol dependence: a Canadian trial","volume":"9","author":"Romach","year":"2002","journal-title":"Canadian Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"227-33","DOI":"10.1093\/alcalc\/agh151","article-title":"Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?","volume":"40","author":"Rubio","year":"2005","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0081|cit81","unstructured":"Rybakowski JK Volpicelli JR Ziolkowski M Drinking relapse in male alcoholics during treatment with naltrexone, lithium or carbamazepine 152nd Annual Meeting of American Psychiatric Association 1999"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"202-9","DOI":"10.1093\/alcalc\/35.2.202","article-title":"Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study","volume":"35","author":"Tempesta","year":"2000","journal-title":"Alcohol and Alcoholism"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1530-0277.2011.01645.x","article-title":"Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate","volume":"36","author":"Prisciandaro","year":"2012","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1399-5618.2011.00973.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report","volume":"14","author":"Tolliver","year":"2012","journal-title":"Bipolar Disorders"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"von Bardeleben U Knoch H Biedert E Ihde T Ladewig D Randomized open efficacy study of naltrexone vs acamprosate vs disulfiram combined with cognitive-behavioral psychotherapy in preventing alcohol relapse Symposium on Basic and Clinical Science of Substance Related Disorders 1998 45 48","DOI":"10.1159\/000059537"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/appi.psy.42.2.110","article-title":"Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed","volume":"42","author":"Weinrieb","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0087|cit87","unstructured":"Combined pharmacotherapies for alcoholism https:\/\/clinicaltrials.gov\/study\/NCT00768508"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"176A","DOI":"10.1111\/j.1530-0277.2010.01210.x","article-title":"Oral naltrexone treatment for alcohol dependence in schizophrenia is not effective for smoking cessation","volume":"34","author":"Szombathyne-Meszaros","year":"2010","journal-title":"Alcohol, Clinical and Experimental Research"},{"issue":"20","key":"10.1002\/14651858.CD015673.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.3390\/jcm10204688","article-title":"Gender differences among Sardinians with alcohol use disorder","volume":"10","author":"Agabio","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012557.pub3","article-title":"Baclofen for alcohol use disorder","author":"Agabio","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"107454","key":"10.1002\/14651858.CD015673.pub2-BIB0091|cit91","first-page":"1","article-title":"Efficacy of medications for the treatment of alcohol use disorder (AUD): a systematic review and meta-analysis considering baseline AUD severity","volume":"209","author":"Agabio","year":"2024","journal-title":"Pharmacological Research"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1521-0391.2012.00270.x","article-title":"Do manualized psychosocial interventions help reduce relapse among alcohol-dependent adults treated with naltrexone or placebo? A meta-analysis","volume":"21","author":"Agosti","year":"2012","journal-title":"American Journal on Addictions"},{"issue":"8","key":"10.1002\/14651858.CD015673.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"e3107","DOI":"10.7759\/cureus.3107","article-title":"Adding psychotherapy to the naltrexone treatment of alcohol use disorder: meta-analytic review","volume":"10","author":"Ahmed","year":"2018","journal-title":"Cureus"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.amepre.2022.03.025","article-title":"Alcohol consumption and 15 causes of fatal injuries: a systematic review and meta-analysis","volume":"63","author":"Alpert","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"issue":"CD008537","key":"10.1002\/14651858.CD015673.pub2-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008537.pub2","article-title":"Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0096|cit96","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0097|cit97","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0098|cit98","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0099|cit99","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0100|cit100","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0101|cit101","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR)","author":"American Psychiatric Association","year":"2022"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archpsyc.1996.01830030047008","article-title":"The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies","volume":"53","author":"Anton","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"7454","key":"10.1002\/14651858.CD015673.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40290-024-00526-x","article-title":"Endpoints for pharmacotherapy trials for alcohol use disorder","volume":"38","author":"Belnap","year":"2024","journal-title":"Pharmaceutical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0105|cit105","first-page":"129","article-title":"An evaluation of cognitive behavioral therapy for substance use disorder: a systematic review and application of the Society of Clinical Psychology criteria for empirically supported treatments","volume":"30","author":"Boness","year":"2023","journal-title":"Clinical Psychology (New York)"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/add.13676","article-title":"Screening, Brief Intervention and Referral to Treatment (SBIRT): rationale, program overview and cross-site evaluation","volume":"112 Suppl 2","author":"Bray","year":"2017","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"issue":"10200","key":"10.1002\/14651858.CD015673.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","article-title":"Alcohol use disorders","volume":"394","author":"Carvalho","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD015673.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/HYPERTENSIONAHA.124.22703","article-title":"Alcohol intake and risk of hypertension: a systematic review and dose-response meta-analysis of nonexperimental cohort studies","volume":"81","author":"Cecchini","year":"2024","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0140-6736(15)00194-4","article-title":"Alcohol use disorders","volume":"387","author":"Connor","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0111|cit111","unstructured":"Covidence Veritas Health Innovation 2023"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0112|cit112","first-page":"144","article-title":"Defining risk drinking","volume":"34","author":"Dawson","year":"2011","journal-title":"Alcohol Research & Health"},{"issue":"10","key":"10.1002\/14651858.CD015673.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/00005053-199310000-00006.","article-title":"Treatment of substance abuse in severely mentally ill patients","volume":"181","author":"Drake","year":"1993","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0114|cit114","first-page":"179","article-title":"Assessing craving for alcohol","volume":"23","author":"Drobes","year":"1999","journal-title":"Alcohol Research & Health"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD015673.pub2-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007025.pub4","article-title":"Motivational interviewing for the prevention of alcohol misuse in young adults","author":"Foxcroft","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/ajp.150.1.28","article-title":"Network therapy for addiction: a model for office practice","volume":"150","author":"Galanter","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"50","key":"10.1002\/14651858.CD015673.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"e13566","DOI":"10.1097\/MD.0000000000013566","article-title":"Association between alcoholic interventions and abstinence rates for alcohol use disorders: a meta-analysis","volume":"97","author":"Gao","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"10152","key":"10.1002\/14651858.CD015673.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"GBD 2016 Alcohol Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"10352","key":"10.1002\/14651858.CD015673.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"GBD 2019 Cancer Risk Factors Collaborators","year":"2022","journal-title":"Lancet"},{"issue":"10347","key":"10.1002\/14651858.CD015673.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","article-title":"Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020","volume":"400","author":"GBD 2020 Alcohol Collaborators","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012576.pub3","article-title":"Music therapy for people with substance use disorders","author":"Ghetti","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"106128","DOI":"10.1016\/j.addbeh.2019.106128","article-title":"The epidemiology of alcohol use disorders cross-nationally: findings from the world mental health surveys","volume":"102","author":"Glantz","year":"2020","journal-title":"Addictive Behaviors"},{"issue":"10","key":"10.1002\/14651858.CD015673.pub2-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011723.pub2","article-title":"Mindfulness-based interventions for substance use disorders","author":"Goldberg","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD015673.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/ADM.0000000000000338","article-title":"Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis","volume":"11","author":"Grant","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"7650","key":"10.1002\/14651858.CD015673.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5694\/mja2.51254","article-title":"New Australian guidelines for the treatment of alcohol problems: an overview of recommendations","volume":"215 Suppl 7","author":"Haber","year":"2021","journal-title":"Medical Journal of Australia"},{"issue":"11","key":"10.1002\/14651858.CD015673.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1176\/appi.ajp.21090963","article-title":"Defining recovery from alcohol use disorder: development of an NIAAA research definition","volume":"179","author":"Hagman","year":"2022","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/add.16325","article-title":"Behavioural self-control training versus motivational enhancement therapy for individuals with alcohol use disorder with a goal of controlled drinking: a randomized controlled trial","volume":"119","author":"Hammarberg","year":"2024","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brat.2005.06.006","article-title":"Acceptance and commitment therapy: model, processes and outcomes","volume":"44","author":"Hayes","year":"2006","journal-title":"Behaviour Research and Therapy"},{"issue":"10","key":"10.1002\/14651858.CD015673.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41386-020-00950-y","article-title":"Addiction as a brain disease revised: why it still matters, and the need for consilience","volume":"46","author":"Heilig","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0137|cit137","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0138|cit138","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook\/archive\/v6.4"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3109\/00952990.2013.796961","article-title":"Naltrexone (50 mg) plus psychotherapy in alcohol-dependent patients: a meta-analysis of randomized controlled trials","volume":"39","author":"Jarosz","year":"2013","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012880.pub2","article-title":"Alcoholics anonymous and other 12-step programs for alcohol use disorder","author":"Kelly","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD015673.pub2-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009269.pub4","article-title":"Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users","author":"Klimas","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD015673.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S2215-0366(19)30213-5","article-title":"Prevention, screening, and treatment for heavy drinking and alcohol use disorder","volume":"6","author":"Knox","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD015673.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/appi.ajp.20230488","article-title":"Overview of alcohol use disorder","volume":"180","author":"Kranzler","year":"2023","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.08.004","article-title":"An initial meta-analysis of acceptance and commitment therapy for treating substance use disorders","volume":"155","author":"Lee","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013071.pub2","article-title":"Testosterone replacement in men with sexual dysfunction","author":"Lee","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006266.pub2","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","author":"Leone","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0147|cit147","first-page":"78","article-title":"Cognitive-behavioral coping-skills therapy for alcohol dependence. Current status and future directions","volume":"23","author":"Longabaugh","year":"1999","journal-title":"Alcohol Research & Health"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15288\/jsas.2005.s15.179","article-title":"Origins, issues and options in the development of the combined behavioral intervention","volume":"S15","author":"Longabaugh","year":"2005","journal-title":"Journal of Studies on Alcohol and Drugs. Supplement"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41572-022-00406-1","article-title":"Hazardous drinking and alcohol use disorders","volume":"8","author":"MacKillop","year":"2022","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"108442","DOI":"10.1016\/j.jsat.2021.108442","article-title":"The principles and practices of psychoeducation with alcohol or other drug use disorders: a review and brief guide","volume":"126","author":"Magill","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1002\/14651858.CD015673.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000481348","article-title":"Reduced drinking in alcohol dependence treatment, what is the evidence?","volume":"23","author":"Mann","year":"2017","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15288\/jsads.2014.s17.68","article-title":"Psychosocial approaches to alcohol use disorders since 1940: a review","volume":"Suppl 75","author":"McCrady","year":"2014","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"13","key":"10.1002\/14651858.CD015673.pub2-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: defining what really matters to patients","volume":"312","author":"McGlothlin","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index","volume":"168","author":"McLellan","year":"1980","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0155|cit155","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013591.pub2","article-title":"Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity","author":"Metzendorf","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0156|cit156","volume-title":"Project MATCH Mono Graph Series","volume":"4","author":"Miller","year":"1995"},{"issue":"11","key":"10.1002\/14651858.CD015673.pub2-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012557.pub2","article-title":"Baclofen for alcohol use disorder","author":"Minozzi","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015042.pub2","article-title":"Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy","author":"Minozzi","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12955-020-01344-w","article-title":"How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods","volume":"18","author":"Mouelhi","year":"2020","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0160|cit160","volume-title":"Helping Patients Who Drink Too Much: A Clinician\u2019s Guide","author":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","year":"2017"},{"issue":"9752","key":"10.1002\/14651858.CD015673.pub2-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.drugalcdep.2018.01.019","article-title":"Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: a national observational cohort study in England","volume":"186","author":"Peacock","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"e208279","DOI":"10.1001\/jamanetworkopen.2020.8279","article-title":"Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis","volume":"3","author":"Ray","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000365284","article-title":"Prevalence of and potential influencing factors for alcohol dependence in Europe","volume":"21","author":"Rehm","year":"2015","journal-title":"European Addiction Research"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0166|cit166","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"9","key":"10.1002\/14651858.CD015673.pub2-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/add.12231","article-title":"Alcohol use disorders and mortality: a systematic review and meta-analysis","volume":"108","author":"Roerecke","year":"2013","journal-title":"Addiction"},{"issue":"13","key":"10.1002\/14651858.CD015673.pub2-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"e008202","DOI":"10.1161\/JAHA.117.008202","article-title":"Sex-specific associations between alcohol consumption and incidence of hypertension: a systematic review and meta-analysis of cohort studies","volume":"7","author":"Roerecke","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"10.1002\/14651858.CD015673.pub2-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001867.pub3","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD015673.pub2-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004332.pub2","article-title":"Acamprosate for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9662","key":"10.1002\/14651858.CD015673.pub2-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0140-6736(09)60009-X","article-title":"Alcohol-use disorders","volume":"373","author":"Schuckit","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1478-4505-4-21","article-title":"Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations","volume":"4","author":"Sch\u00fcnemann","year":"2006","journal-title":"Health Research Policy and Systems"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0173|cit173","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JPT Santesso N Deeks JJ Glasziou P Akl EA Guyatt GH Chapter 15: Interpreting results and drawing conclusions [last updated August 2023]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2468-2667(19)30231-2","article-title":"National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study","volume":"5","author":"Shield","year":"2020","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"e20210217","DOI":"10.36416\/1806-3756\/e20210217","article-title":"What is the minimal clinically important difference, and why does it matter?","volume":"47","author":"Sim\u00f5es","year":"2021","journal-title":"Jornal Brasileiro de Pneumologia"},{"issue":"2","key":"10.1002\/14651858.CD015673.pub2-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1002\/14651858.CD015673.pub2-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"e011827","DOI":"10.1136\/bmjopen-2016-011827","article-title":"Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression","volume":"6","author":"Slade","year":"2016","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0178|cit178","volume-title":"State-Trait Anxiety Inventory (STAI, Form Y)","author":"Spielberger","year":"1983"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neubiorev.2021.11.019","article-title":"Alcohol-medication interactions: a systematic review and meta-analysis of placebo-controlled trials","volume":"132","author":"Traccis","year":"2022","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"02","DOI":"10.35946\/arcr.v40.3.02","article-title":"Epidemiology of recovery from alcohol use disorder","volume":"40","author":"Tucker","year":"2020","journal-title":"Alcohol Research: Current Reviews"},{"issue":"6","key":"10.1002\/14651858.CD015673.pub2-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/alcalc\/agac043","article-title":"The added value of pharmacotherapy to cognitive behavior therapy and vice versa in the treatment of alcohol use disorders: a systematic review","volume":"57","author":"Amsterdam","year":"2022","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-031-32483-3_20","volume-title":"Alcohol and Alcohol-Related Diseases","author":"Votaw","year":"2023"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2215-0366(14)00092-3","article-title":"Placebo effects in psychiatry: mediators and moderators","volume":"2","author":"Weimer","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.alcohol.2022.07.005","article-title":"Alcohol and aging \u2013 an area of increasing concern","volume":"107","author":"White","year":"2023","journal-title":"Alcohol"},{"issue":"1","key":"10.1002\/14651858.CD015673.pub2-BIB0185|cit185","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02791072.1999.10471721","article-title":"Assertive community treatment for patients with chronic and severe mental illness who abuse drugs","volume":"31","author":"Wingerson","year":"1999","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"10.1002\/14651858.CD015673.pub2-BIB0186|cit186","first-page":"313","article-title":"Behavioral therapy across the spectrum","volume":"33","author":"Witkiewitz","year":"2011","journal-title":"Alcohol Research and Health"},{"issue":"9","key":"10.1002\/14651858.CD015673.pub2-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"eaax4043","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Science Advances"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"01","DOI":"10.35946\/arcr.v40.3.01","article-title":"What is recovery?","volume":"40","author":"Witkiewitz","year":"2020","journal-title":"Alcohol Research: Current Reviews"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0189|cit189","unstructured":"World Health Organization International Classification of Diseases - 10th Revision; 1992 apps.who.int\/iris\/handle\/10665\/37958"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0190|cit190","unstructured":"World Health Organization International Classification of Diseases - 10th Revision. Volume 2 instruction manual; 2010 https:\/\/icd.who.int\/browse10\/Content\/statichtml\/ICD10Volume2_en_2010.pdf"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0191|cit191","volume-title":"Update of the Mental Health Gap Action Programme (mhGAP) Guidelines for Mental, Neurological and Substance Use Disorders","author":"World Health Organization","year":"2015"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0192|cit192","unstructured":"World Health Organization International Classification of Diseases - 11th Edition (ICD-11), 2022 https:\/\/icd.who.int\/en"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0193|cit193","unstructured":"World Health Organization Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders - 3rd edition; 20 November 2023 https:\/\/www.who.int\/publications\/i\/item\/9789240084278"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0194|cit194","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015673.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A self-rating depression scale","volume":"12","author":"Zung","year":"1965","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD015673.pub2-BIB0196|cit196","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015673","article-title":"Combined pharmacological and psychosocial interventions for alcohol use disorder","author":"Agabio","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:34:48Z","timestamp":1792992888000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015673.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":196,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015673.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}